University of New Hampshire Franklin Pierce School of Law is expanding its focus on specialized legal education with the fall 2025 launch of a new concentration in Health and Life Sciences Law.
Hybrid J.D. students may pursue the new health and life sciences focus, which will highlight the intersection of healthcare, science, IP and business law.
Lucy Hodder, director of the health and life sciences program, said the added concentration in the hybrid J.D. will incorporate the critical legal issues facing patients, providers and businesses in the drug and device industry.
“Our goal is to teach students to develop pathways to sustainable solutions in our health care and life sciences innovation space,” she said.
The expanded interdisciplinary and experiential course offerings will help prepare graduates for advanced careers in an expanding global economy and will address the development, distribution and regulation of biological products and services, including biotech, biologics and pharmaceuticals.
Megan Carpenter, dean at UNH Law, said employers increasingly want to hire law graduates who have domain knowledge so they can hit the ground running.
“We have expanded our focus on specialized legal education to launch the careers of the next leaders in health and life sciences law,” she said.
The mostly online hybrid J.D. at UNH Law is aimed at professionals with experience in IP, technology, healthcare, life sciences and related fields. The need for lawyers with IP and/or life sciences law experience exists in many industries, such as health care and medicine, tech and biopharma, business and entrepreneurship and within government and policy driven organizations.
